Total Payments
$223,198
2024 Payments
$115.89
Companies
25
Transactions
283
Medicare Patients
761
Medicare Billing
$75,613
Payment Breakdown by Category
Other$113,157 (50.7%)
Consulting$58,105 (26.0%)
Research$28,140 (12.6%)
Travel$17,775 (8.0%)
Food & Beverage$6,013 (2.7%)
Education$9.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $111,522 | 49 | 50.0% |
| Consulting Fee | $58,105 | 21 | 26.0% |
| Unspecified | $28,140 | 18 | 12.6% |
| Travel and Lodging | $17,775 | 77 | 8.0% |
| Food and Beverage | $6,013 | 116 | 2.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,635 | 1 | 0.7% |
| Education | $9.00 | 1 | 0.0% |
Payments by Type
General
$195,058
265 transactions
Research
$28,140
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $63,183 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $44,051 | 33 | $0 (2019) |
| Genentech USA, Inc. | $25,924 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $25,549 | 58 | $0 (2023) |
| F. Hoffmann-La Roche AG | $19,163 | 14 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $13,245 | 18 | $0 (2019) |
| Alcon Research LLC | $10,526 | 7 | $0 (2023) |
| GENZYME CORPORATION | $10,246 | 18 | $0 (2024) |
| Genentech, Inc. | $4,622 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,835 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.89 | 2 | Regeneron Healthcare Solutions, Inc. ($100.86) |
| 2023 | $10,741 | 25 | Alcon Research LLC ($4,950) |
| 2022 | $16,135 | 37 | AstraZeneca Pharmaceuticals LP ($10,030) |
| 2021 | $12,682 | 17 | AstraZeneca Pharmaceuticals LP ($5,143) |
| 2020 | $37,503 | 43 | Regeneron Healthcare Solutions, Inc. ($17,138) |
| 2019 | $74,848 | 95 | Regeneron Healthcare Solutions, Inc. ($45,872) |
| 2018 | $21,912 | 33 | Novartis Pharmaceuticals Corporation ($10,773) |
| 2017 | $49,261 | 31 | NOVARTIS PHARMACEUTICALS CORPORATION ($22,357) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/29/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 02/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/22/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Immunology | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Respiratory | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2023 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Allergy and Immunology | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Respiratory | ||||||
| 05/03/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: DERMATOLOGY | ||||||
| 04/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $114.31 | General |
| Category: Respiratory | ||||||
| 04/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $101.37 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $95.65 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2023 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $18.35 | General |
| 04/14/2023 | Genentech, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $219.83 | General |
| Category: Immunology | ||||||
| 04/13/2023 | Genentech, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: Immunology | ||||||
| 04/13/2023 | Genentech, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $303.97 | General |
| Category: Immunology | ||||||
| 04/13/2023 | Genentech, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $197.77 | General |
| Category: Immunology | ||||||
| 03/29/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/22/2023 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Allergy and Immunology | ||||||
| 03/15/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2023 | Alcon Research LLC | Pataday (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Ophthalmology | ||||||
| 02/15/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Dermatology | ||||||
| 02/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 01/25/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/20/2023 | Alcon Research LLC | Pataday (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $25,050 | 17 |
| A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair in Subjects With Moderate to Severe Persistent Asthma Who Are Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists | F. Hoffmann-La Roche AG | $3,090 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 110 | 322 | $26,278 | $5,643 |
| 2022 | 10 | 220 | 1,890 | $84,503 | $19,181 |
| 2021 | 8 | 190 | 1,862 | $45,065 | $25,154 |
| 2020 | 9 | 241 | 2,257 | $50,305 | $25,636 |
Total Patients
761
Total Services
6,331
Medicare Billing
$75,613
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $6,930 | $1,427 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,511 | $1,361 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $3,910 | $1,076 | 27.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 30 | 154 | $5,367 | $1,021 | 19.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 14 | 51 | $1,454 | $286.42 | 19.7% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 11 | 55 | $1,650 | $283.86 | 17.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 13 | $1,456 | $188.69 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 64 | $21,120 | $6,066 | 28.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 18 | 1,061 | $18,467 | $3,018 | 16.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 28 | 370 | $10,332 | $2,176 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $9,036 | $1,903 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 26 | $5,330 | $1,446 | 27.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 11 | 11 | $4,257 | $1,442 | 33.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 14 | 138 | $4,830 | $1,194 | 24.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 112 | $6,965 | $1,103 | 15.8% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 15 | 67 | $1,910 | $425.04 | 22.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 21 | 21 | $2,256 | $407.59 | 18.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 23 | 853 | $13,305 | $9,969 | 74.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 68 | $6,162 | $4,310 | 69.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $6,120 | $3,063 | 50.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 32 | $3,834 | $2,781 | 72.5% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 22 | 333 | $5,994 | $2,112 | 35.2% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 13 | 430 | $3,010 | $1,379 | 45.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 104 | $5,200 | $1,113 | 21.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 16 | 18 | $1,440 | $427.14 | 29.7% |
About Dr. Bobby Lanier, MD
Dr. Bobby Lanier, MD is a Allergy & Immunology healthcare provider based in Benbrook, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114984259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bobby Lanier, MD has received a total of $223,198 in payments from pharmaceutical and medical device companies, with $115.89 received in 2024. These payments were reported across 283 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($111,522).
As a Medicare-enrolled provider, Lanier has provided services to 761 Medicare beneficiaries, totaling 6,331 services with total Medicare billing of $75,613. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Benbrook, TX
- Active Since 05/01/2006
- Last Updated 01/12/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1114984259
Products in Payments
- DUPIXENT (Biological) $73,315
- Xolair (Biological) $49,708
- XOLAIR (Biological) $37,135
- Pataday (Drug) $10,526
- FASENRA (Drug) $9,289
- FASENRA (Biological) $8,747
- MK-7264 (Drug) $8,390
- TEZSPIRE (Biological) $7,139
- PAZEO (Drug) $6,051
- NUCALA (Biological) $2,818
- GILENYA (Drug) $493.00
- CINRYZE (Drug) $226.76
- Odactra (Drug) $210.41
- EUCRISA (Drug) $130.90
- CUVITRU (Biological) $104.99
- CINQAIR (Biological) $61.18
- PRE-PEN (Drug) $58.71
- ADBRY (Biological) $55.87
- CUTAQUIG (Biological) $42.98
- SYMBICORT (Drug) $39.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.